Display options
Cite
Szarmach J, Cubała WJ, Landowski J, et al. No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study. J Clin Exp Dent. 2017;9(4):e527-e530doi: 10.4317/jced.53631.
Szarmach, J., Cubała, W. J., Landowski, J., & Chrzanowska, A. (2017). No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study. Journal of clinical and experimental dentistry, 9(4), e527-e530. https://doi.org/10.4317/jced.53631
Szarmach, Joanna, et al. "No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study." Journal of clinical and experimental dentistry vol. 9,4 (2017): e527-e530. doi: https://doi.org/10.4317/jced.53631
Szarmach J, Cubała WJ, Landowski J, Chrzanowska A. No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study. J Clin Exp Dent. 2017 Apr 01;9(4):e527-e530. doi: 10.4317/jced.53631. eCollection 2017 Apr. PMID: 28469817; PMCID: PMC5410672.
Copy Download .nbib Format: NLM
Share it on

J Clin Exp Dent. 2017 Apr 01;9(4):e527-e530. doi: 10.4317/jced.53631. eCollection 2017 Apr.

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study.

Journal of clinical and experimental dentistry

Joanna Szarmach, Wiesław-Jerzy Cubała, Jerzy Landowski, Anna Chrzanowska

Affiliations

  1. Department of Psychiatry, Medical University of Gda?sk, Gda?sk, Poland.
  2. Radiometer Sp. z o.o., Warsaw, Poland.

PMID: 28469817 PMCID: PMC5410672 DOI: 10.4317/jced.53631

Abstract

BACKGROUND: Salivary α-amylase (sAA) activity alternations are observed in major depressive disorder (MDD) being associated with depression severity and its specific psychopathological dimensions with anxiety being attributed to distress. No data is available on sAA in MDD according to Hamilton Rating Scale for Depression (HAMD-17) and State-Trait Anxiety Inventory (STAI). The exploratory study examines whether and to what extent baseline sAA level is interrelated to the psychopathological features including severity of symptoms and specific psychopathological dimensions.

MATERIAL AND METHODS: The basal, non-stimulated sAA activity was studied in 20 non-late-life adult, treatment-naïve MDD patients with short-illness-duration and in 20 age- and sex-matched healthy controls along with psychometric assessments with Hamilton Rating Scale for Depression (HAMD-17) and Spielberger State-Trait Anxiety Inventory (STAI).

RESULTS: Significantly lower (

CONCLUSIONS: Low baseline sAA levels in MDD with no correlations between sAA and psychopathological features including severity of symptoms and specific psychopathological dimensions was found.

Conflict of interest statement

Conflict of interest statement:None of the authors reports conflicts of interest.

References

  1. J Clin Exp Dent. 2012 Oct 01;4(4):e237-43 - PubMed
  2. Int J Psychiatry Clin Pract. 2010 Nov;14(4):268-73 - PubMed
  3. J Affect Disord. 2014 Mar;157:14-7 - PubMed
  4. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):220-4 - PubMed
  5. Anesth Analg. 2005 Dec;101(6):1873-6 - PubMed
  6. Biol Psychol. 2012 Mar;89(3):539-44 - PubMed
  7. Int J Psychophysiol. 2008 Jul;69(1):33-40 - PubMed
  8. Biol Psychol. 2010 Sep;85(1):179-81 - PubMed
  9. Neuro Endocrinol Lett. 2014;35(8):741-5 - PubMed
  10. Pharmacol Biochem Behav. 2013 Oct;111:128-35 - PubMed
  11. Psychoneuroendocrinology. 2013 Jun;38(6):729-43 - PubMed
  12. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62 - PubMed

Publication Types